Biomarkers of Kidney Disease

Table of Contents Available

Author: Charles Edelstein, MD, PhD
Affiliation:
Publisher: Elsevier Science and Technology
Publication Date: 2017

ISBN 10: 0128030143
ISBN 13: 9780128030141
eISBN: 9780128030356
Edition: 2nd

Description:

Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker. The latest techniques for biomarker detection, including metabolomics and proteomics are covered in the book. This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and preeclampsia. New chapters include biomarkers of cardiovascular disease in patients with CKD, biomarkers of Polycystic Kidney Disease, and biomarkers and the role of nanomedicine.

Table of Contents

FRONT MATTER

CHAPTER ONE: CHARACTERISTICS OF AN IDEAL BIOMARKER OF KIDNEY DISEASES

CHAPTER TWO: STATISTICAL CONSIDERATIONS IN ANALYSIS AND INTERPRETATION OF BIOMARKER STUDIES

CHAPTER THREE: THE ROLE OF METABOLOMICS IN THE STUDY OF KIDNEY DISEASES AND IN THE DEVELOPMENT OF DIAGNOSTIC TOOLS

CHAPTER FOUR: THE ROLE OF PROTEOMICS IN THE STUDY OF KIDNEY DISEASES AND IN THE DEVELOPMENT OF DIAGNOSTIC TOOLS

CHAPTER FIVE: CYSTATIN C AS A MULTIFACETED BIOMARKER IN KIDNEY DISEASE AND ITS ROLE IN DEFINING “SHRUNKEN PORE SYNDROME”

CHAPTER SIX: BIOMARKERS IN ACUTE KIDNEY INJURY

CHAPTER SEVEN: BIOMARKERS OF EXTRA-RENAL COMPLICATIONS OF AKI

CHAPTER EIGHT: BIOMARKERS IN KIDNEY TRANSPLANTATION

CHAPTER NINE: BIOMARKERS OF RENAL CANCER

CHAPTER TEN: PROTEOMICS AND ADVANCEMENTS IN URINARY BIOMARKERS OF DIABETICS KIDNEY DISEASE

CHAPTER ELEVEN: BIOMARKERS OF CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE

CHAPTER TWELVE: DIAGNOSTIC AND PROGNOSTIC BIOMARKERS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

CHAPTER THIRTEEN: BIOMARKERS IN GLOMERULAR DISEASE

CHAPTER FOURTEEN: BIOMARKERS IN PREECLAMPSIA

Topics within this title:

• accuracy
• acute kidney disease
• Acute kidney injury
• ADPKD
• Albuminuria
• angiogenic proteins
• Animal models
• biological markers
• Biomarker
• biomarker development
• Biomarker discovery
• biomarker qualification
• biomarkers
• brush-border enzymes
• Cancer
• chemokines
• chronic kidney disease
• CKD
• combinatorial biomarkers
• creatinine
• Cystatin C
• Diabetes
• diabetes mellitus
• diagnostic
• Diagnostics
• drug toxicity
• false positive rate
• Focal segmental glomerulosclerosis
• genes
• genetic markers
• GFR
• GFR-estimating equations
• hypertension
• IgA nephropathy
• IGFBP7
• incremental value
• Individualized medicine
• internal and external validation
• Kidney Disease
• Kidney Diseases
• kidney failure
• kidney injury molecule-1
• lupus nephritis
• mass spectrometry
• membranous nephropathy
• minimal change disease
• molecular markers
• natriuretic peptides
• nephropathy
• neutrophil gelatinase-associated lipocalin
• NGAL
• NMR spectroscopy
• organ dysfunction
• PIGF
• plasma markers
• Polycystic Kidney
• Polycystic Kidney Disease
• predicting response
• Preeclampsia
• prognosis
• Prognostic
• proinflammatory cytokines
• protein identification
• proteinuria
• proteomics
• regulatory requirements
• renal blood flow
• Renal Cancer
• renal reserve
• ROC curves
• serum biomarker
• serum cytokines
• Shrunken Pore Syndrome
• Syndrome
• TIMP2
• tissue markers
• total kidney volume
• troponin
• true positive rate
• urinary glycosaminoglycans
• urine
• urine biomarker